$4.23 0.18 (+4.44%)
2/13/2012 3:59 PM

Pain Therapeutics, Inc. (NASDAQ:PTIE)

CAPS Rating: 4 out of 5

A biopharmaceutical company that develops novel drugs for pain management and oncology.

Recs

0
Player Avatar SnoopyDancing (< 20) Submitted: 12/29/2008 3:54:02 PM : Outperform Start Price: $5.73 PTIE Score: +9.11

New joint venture with King pharma may bring an abuse-free oxycontin to market which would be a blockbuster for the legal pharma market.

Report this Post Add Comment

Featured Broker Partners


Advertisement